Tuesday, April 04, 2023

#AIEye #Podcast: #Stocks discussed: (NYSE: $PERF) (NasdaqCM: $GFAI)



 

 

#AIEye #Podcast: #Stocks discussed: (NYSE: $PERF) (NasdaqCM: $GFAI)

 

Perfect Corp Announces Launch of AI-Powered Avatar Generator, and Guardforce AI Rallies Following Signing of AIoT Robot Advertising Contract

 

Global #AI in #DrugDiscovery Market to Reach $4.19B by 2028

 

Vancouver, Kelowna, Delta, BC – April 4, 2023  – Investorideas.com, a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-watching stock news, deal tracker and advancements in artificial intelligence.

 

Today’s podcast is sponsored by Fintech Company AppTech Payments Corp. (NasdaqCM:APCX).

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2023/040423-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2023/artificial-intelligence/04041PERF-GFAI.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (NYSE:PERF) (NasdaqCM:GFAI)

 

Perfect Corp. (NYSE:PERF) has announced the launch of an AI-powered avatar generator for its award-winning YouCam Perfect App for iOS and Android. This AI Magic Avatar tool is powered by the company’s advanced Artificial Intelligence Generated Content (AIGC) technology and stable diffusion models, and creates hyper-realistic digital avatars. Perfect Corp.’s CEO and Founder Alice Chang, said:

 

“As consumers look for new ways to express themselves in digital spaces and emerging virtual worlds, avatars have become an essential aspect of communication and digital personas. We are thrilled to introduce the new AI Magic Avatar generator for YouCam Perfect, allowing app users to create fun and dynamic digital avatars with their exact likeness."

 

Guardforce AI Co., Limited (NasdaqCM:GFAI) recently signed an Artificial Intelligence of Things (AIoT) Robot Advertising (RA) contract with a local government office in Macau to promote shows, exhibitions, and forums on approximately 165 of Guardforce AI's robots for a total period of 20 weeks. The AIoT RA model, according to the press release, “enables advertisers to publish advertisements on Guardforce AI's robots and make more informed marketing decisions with data feedback from the Guardforce AI Intelligent Cloud Platform (GFAI ICP).” Olivia Wang, Chairwomen and CEO of Guardforce AI, said:

 

“The ability to leverage data analytics also provides advertisers with continuous feedback, thereby making it easier to refine targeting and achieve intelligent, high-quality, and cost-effective smart advertising. We look forward to accelerated growth this year through our AIoT RA model, both in Macau and other important markets around the world.”

 

Just yesterday, this stock rocketed roughly 166 percent from a trading price of about $7.17 USD to a high of around $19.14. At press time, it has withdrawn about 14 percent, and is trading for roughly $16.70.

 

 

Global AI in Drug Discovery Market to Reach $4.19B by 2028

 

A report published by Vantage Market Research finds that the global AI in Drug Discovery market is projected to grow from $627.1 million USD in 2021 to $4.19 billion by 2028, registering a compound annual growth rate (CAGR) of 41.5 percent in the forecast period. The following excerpt from the report’s description outlines some of the major influences guiding the market’s growth:

 

Factors such as the growing population, the need to expand healthcare access, the rising prevalence of chronic diseases and conditions, a physician shortage, advancements in telecommunications, increasing awareness, government support, and increasing technology adoption are all driving growth in the Artificial Intelligence in Drug Discovery market.

 

Additionally, widespread use by multiple businesses for the identification and screening of existing medicines for the treatment of COVID-19, the COVID-19 outbreak had a beneficial impact on the growth of artificial intelligence in the drug discovery market.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

 

Podcast sponsor


AppTech Payments Corp. (NasdaqCM:APCX) is an innovative Fintech company whose mission is to deliver a better way for businesses to provide their customers with immersive commerce experiences. Commerse™, its all-new, patent-backed technology platform powering seamless omni-channel Commerce Experiences-as-a-Service (CXS), drives highly secure, scalable, cross-border digital banking, text-to-pay, crypto payments and merchant services altogether from a single, unified stack designed to increase operational efficiencies and growth for businesses while providing the economic convenience that their customers demand from today’s commerce experiences. For more information, visit apptechcorp.com.

About Investorideas.com - Big Investing Ideas

We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders.  Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast ,  Cleantech and Climate Change Podcast,  Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast.  We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water. 

 

The Investorideas.com podcasts are also available on Apple Podcasts ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts  and most audio platforms available.

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Disclosure: podcast sponsor AppTech Payments Corp. (NasdaqCM:APCX) is a paid featured Fintech company on Investorideas.com.

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800 665 0411



Get more Technology stock investor ideas - news, articles, podcasts and stock directories

Monday, April 03, 2023

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move: (TSX: $LABS.TO), KIva Confections, NBA and Sequire Cannabis and Psychedelics Conference

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move: (TSX: $LABS.TO), KIva Confections, NBA and Sequire Cannabis and Psychedelics Conference

 


Delta, Kelowna, BC, April 3, 2023 (Investorideas.com Newswire), investorideas.com,  a global news source covering leading sectors including marijuana and hemp stocks and its potcast site  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2023/040323-Cannabis.mp3

 

Read this in full at https://www.investorideas.com/news/2023/cannabis-potcasts/04031LABS-Kiva-NBA-Sequire-Psychedelics.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

In today’s podcast we go over a few industry announcements, changes to NBA drug testing policy as well as upcoming events.

 

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) and VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIFannounced the completion of the previously announced plan of arrangement under section 192 of the Canada Business Corporations Act, pursuant to which MediPharm has acquired all of the issued and outstanding common shares of VIVO in an all-equity business combination transaction effective April 1, 2023. The Arrangement combines two highly complementary businesses, creating a unique and market differentiating international medical cannabis leader.

 

Key Transaction Highlights:

       Leading Pharmaceutical Cannabis Company: The acquisition of VIVO will add: established Australian and German medical cannabis brand Beacon Medical; an industry-leading medical cannabis clinic business Harvest Medicine; and a longstanding Canadian medical sales platform Canna Farms Medical.

       Direct to Patient Sales:(1)(3) Canna Farms was the first Licensed Producer in British Columbia, and its medical sales channel, Canna Farms Medical, has supported over 60,000 patients since 2014.(6) Following the Arrangement, it is anticipated that this platform will provide patients with a more diverse product portfolio that includes existing MediPharm products. Direct to patient sales generally result in a better gross margin with the ability to bypass provincial distributors. VIVO's clinic business Harvest Medicine will allow real-time product feedback and clinical insights on MediPharm products.

       Diversified Revenue Profile with Strong Canadian Base: (1)(3) The pro-forma combined company resulting from the Arrangement (the "Combined Company") is expected to provide fulsome Canadian market coverage with cultivation and manufacturing expertise, and a full suite of dried flower & derivative products with both established medical and adult-use wellness distribution channels.

       Expanding International Medical Cannabis Opportunity:(1)(2)(3)(4) The pro-forma Combined Company's international distribution will cover European and Asia-Pacific markets through established, revenue-generating agreements. The VIVO Napanee Ontario facility is EU-GMP certified for cultivating and packaging flower and the MediPharm Barrie Ontario facility is GMP certified for non-flower alternative format medical products. With two distinct international platforms, the pro-forma Combined Company is expected to open many new product offerings for existing distribution channels and geographies. The pro-forma Combined Company would have annualized international revenue of over $20M, representing approximately 40% of total revenues.(5)

       Revenue and Cost Synergies Realizable in the Near-Term:(1)(2)(3)(4) Using forecasts derived collaboratively by both management teams, along with revenue and cost synergy estimates, the pro-forma Combined Company aims to find positive EBITDA(6) synergies to the magnitude of between $7M to $9M on an annualized basis, and could reach positive EBITDA and cash flow in the first half of 2024.

       Balance Sheet Strength:(1)(2)(3)(4) Anticipated combined cash position of approximately $26 million (as reported December 31, 2022) and unencumbered ownership of all major assets. This strength is expected to provide confidence in the Combined Company's balance sheet to execute on its strategic growth roadmap, despite the macro backdrop of capital markets that continue to soften.

       Ownership Ratio Finalized: The Combined Company is owned approximately 73.1% by former MediPharm shareholders and approximately 26.9% by former VIVO shareholders.

 

"We are very excited to be starting a new chapter in the evolution of MediPharm Labs. VIVO is a strong cultural fit, and a great strategic fit. Together the two organizations have a much clearer path to profitability. I want to welcome all the VIVO employees and thank the teams on both sides that worked over many months to help bring us together," said David Pidduck, Chief Executive Officer of MediPharm.

 

"Our entire team has been working long and hard to achieve our goals of growth and profitability and this deal is a manifestation of that hard work. I cannot thank the team enough," said Ray Laflamme, Chief Executive Officer of VIVO. "Canna Farms and VIVO have been huge parts of my life and our team's lives for the past ten years. Personally, I am proud to be part of the cannabis industry, and I am proud that our company and our leadership are being recognized and validated by MediPharm's desire to merge with us. We are very proud of VIVO and the amazing new company that we will create with MediPharm."

 

As a result of the Arrangement, VIVO has become a wholly-owned subsidiary of MediPharm, and the VIVO Shares are anticipated to be de-listed from the Toronto Stock Exchange on or about April 4, 2023.

 

Kiva Confections, California's market leader in premium, award-winning cannabis edibles, recently announced a partnership with iconic burger chain Fatburger for this coming 4/20 holiday to release a limited edition cannabis-infused Kiva x Fatburger Ketchup. The first-of-its-kind Cannabis Ketchup, available for a limited time only beginning April 6th at participating Artist Tree and Sweet Flower Los Angeles locations, encourages consumers to heighten their favourite munchies, Fatburger's famous burgers and french fries, while furthering Kiva's mission to continue the conversation around cannabis normalisation in California and beyond.

 

The partnership between the two nationally recognized brands supports the increased interest around cannabis as it continues to be integrated into consumers' daily lifestyles. Currently, recreational cannabis sales continue to grow in over 20 states across the U.S., and the number of cannabis users in the country is predicted to reach nearly 71 million users by 2030.

 

"As the market leader in cannabis edibles, we're thrilled to continue pioneering innovative, yet everyday products that pave the way for cannabis normalisation," commented Kristi Palmer, Co-Founder of Kiva Confections. "We can't think of a better partner for this than our favourite West Coast burger chain. Though the partnership may seem unconventional, Fatburger and Kiva are both California-founded and beloved institutions. What better way for cannabis fans to celebrate 420 than with a delicious, elevated munchies meal - and for the cannacurious to take their first dip into cannabis one fry at a time."

 

Kiva x Fatburger Ketchup will feature 10mg of THC per packet, making it the ultimate "condiment" for all of your Fatburger made-to-order burgers and fries ahead of the popular 4/20 holiday.

 

"Every year, we look to bring our own special flavour to the 4/20 holiday," said Taylor Fischer, Vice President of Marketing for Fatburger. "Kiva was the perfect fit from a collaboration standpoint as they not only have an incredibly strong California fan base like Fatburger, but the quality of their edibles is unmatched in the cannabis space, similar to how we are viewed in the burger industry. Our special sauce will be sure to take the munchie game to a higher level."

Kiva x Fatburger Infused Ketchup will be available for purchase for a limited time only at select Artist Tree and Sweet Flower Los Angeles locations beginning April 6th, retailing at $5 while supplies last. For more information on the partnership, Kiva x Fatburger Ketchup, upcoming special Kiva x Fatburger events and more, visit kivaconfections.comfatburger.com, or visit the brands on Instagram @madebykiva and @fatburger.

 

In recent news, The NBA will no longer be testing for cannabis, according to a tentative deal between the league and the National Basketball Players Association.

 

The two sides announced the collective bargaining agreement, which still needs to be ratified before it becomes official, on Saturday morning, according to The Athletic.

 

If the CBA is ratified by the players and team governors, the seven-year deal would include a stipulation that cannabis will be removed from the drug testing program and NBA players will no longer be penalised for its use.

 

In a statement posted to Twitter, the National Basketball Players Association said: "Specific details will be made available once a term sheet is finalised."

 

"Since day one, the goal of the NBPA in this negotiation was to protect our players, enrich their lives on and off the court, and establish a framework that recognizes our players as true partners with the governors in both the NBA and the business world at large!" NBPA executive director Tamika Tremaglio said in a tweet.

 

Amid the pandemic, the NBA announced in late 2021 that it would no longer randomly test players for marijuana use after suspending testing in March 2020. At the time, NBA spokesman Mike Bass said the league would instead "focus our random testing program on performance-enhancing products and drugs of abuse."

 

Some NBA athletes – including Hall of Famers Kareem Abdul-Jabbar and Allen Iverson – have been open about their own cannabis use and advocated for cannabis legalisation as have athletes from other leagues, like the NFL, MLB and UFC.

 

Finally, in upcoming events, the Sequire Cannabis & Psychedelics Conference, a free virtual event, will be hosted on Wednesday, April 5 from 10 am to 4 pm ET. It’s gonna be a trip, featuring speakers from the industry’s top companies in the cannabis, CBD, and psychedelic space alongside keynotes and more. Register today to hear more about an industry expected to reach $72 billion annually by 2030. Companies attending will be Numinus Wellness Inc. (TSX: NUMI), Red Light Holland (OTC: TRUFF), Mindset Pharma (CSE: MSETNextleaf Solutions (CSE: OILS), Clever Leaves (NASDAQ: CLVR), High Tide Inc. (NASDAQ: HITI) and Silo Pharma (NASDAQ: SILO).

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Podcasts and most audio platforms available.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research , guest posts and original  articles and podcasts in leading stock sectors.  Learn about investing in stocks and get  investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.     

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

#CryptoCorner #Podcast: #Cryptocurrency #Stocks in the News: (NasdaqCM: $CLSK) (NasdaqGM: $BITF) (NYSE: $BKKT)

 



 

 

#CryptoCorner #Podcast: #Cryptocurrency #Stocks in the News: (NasdaqCM: $CLSK) (NasdaqGM: $BITF) (NYSE: $BKKT)

 

CleanSpark and Bitfarms Post March Updates, and Bakkt Holdings Completes Acquisition of Apex Crypto

 

Vancouver, Kelowna, Delta, BC April 3, 2023 -  Investorideas.com, a leader in crypto and blockchain investing news brings you today’s edition of the Crypto Corner podcast and commentary on what’s driving cryptocurrency stocks and the crypto market.

 

Today’s podcast is sponsored by Fintech Company AppTech Payments Corp. (NasdaqCM:APCX).

 

The Investor ideas Crypto Corner was named one of 14 Best Crypto & Blockchain Podcasts for Jun 2022: https://www.yoreoyster.com/blog/best-crypto-podcasts/

 

Listen to today’s Crypto Corner Podcast:  

https://www.investorideas.com/Audio/Podcasts/2023/040323-CryptoMarket.mp3

 

Read this in full at https://www.investorideas.com/news/2023/crypto-corner/04031CLSK-BITF-BKKT.asp

 

Get the Crypto Corner Podcast on iTunes

 

Get the Crypto corner on Spotify

 

Stocks discussed: (NasdaqCM:CLSK) (NasdaqGM:BITF) (NYSE:BKKT)

 

CleanSpark, Inc. (NasdaqCM:CLSK) has released its unaudited Bitcoin (BTC) mining and operations update for the month ending March 31, 2023. Highlights include the mining of 598 BTC – 502 of which ​​was converted for operations and growth in the month, and a currently deployed fleet of about 67,700 latest-generation bitcoin miners with a hashrate of 6.7 EH/s. Zach Bradford, the company’s CEO, explained:

 

“Our approach to proprietary mining gives us substantial control and flexibility over our destiny and the progress on our Washington expansion is a perfect example. The 50MW expansion is on schedule. The machines have already been purchased and shipping is expected to commence this month. Once those machines are racked and the expansion is energized, our hashrate is expected to increase to about 8.7 EH/s, giving us substantial progress toward our calendar year-end goal of 16 EH/s.”

 

Bitfarms Ltd. (NasdaqGM:BITF) has provided its Bitcoin production and mining operations update for March 2023. Highlights include the mining of 424 BTC, a 4.8 EH/s hashrate capacity online as of March 31, and the sale of 394 BTC for total proceeds of $9.7 million. The company’s Chief Mining Officer, Ben Gagnon, said:

 

“In March, we increased BTC production 17% year-over-year, even with energy curtailment in Quebec and Paraguay as well as continued network growth. In Q1 2023, BTC price increased by 72%, outpacing network difficulty growth of 32.5%. As a result, industry mining revenue is up 31% dollars per TH in the quarter. Continued rising difficulty levels reflect increasing investment and bullish sentiment in the mining industry overall.”

 

Bakkt Holdings, Inc. (NYSE:BKKT) has completed its acquisition of Apex Crypto LLC, the latter of which is described as “a turnkey platform for integrated crypto trading, developed to meet the growing needs of fintechs, trading apps, neobanks and their customers.” Gavin Michael, CEO of Bakkt, commented:

 

"This acquisition marks an exciting new chapter for Bakkt, significantly advancing portions of our crypto roadmap, helping us tap into a universe of 5.8 million crypto-enabled accounts, and further establishing Bakkt as the B2B2C crypto provider of choice. We’re looking forward to welcoming the Apex Crypto team members to Bakkt and working together to accelerate our growth and strategy."

 

Sam Mowers, Investorideas

 

For investors following the sector Investor Ideas has a comprehensive Bitcoin, Blockchain and Digital Currency Stocks Directory

 

Podcast sponsor


AppTech Payments Corp. (NasdaqCM:APCX) is an innovative Fintech company whose mission is to deliver a better way for businesses to provide their customers with immersive commerce experiences. Commerse™, its all-new, patent-backed technology platform powering seamless omni-channel Commerce Experiences-as-a-Service (CXS), drives highly secure, scalable, cross-border digital banking, text-to-pay, crypto payments and merchant services altogether from a single, unified stack designed to increase operational efficiencies and growth for businesses while providing the economic convenience that their customers demand from today’s commerce experiences. For more information, visit apptechcorp.com.

About Investorideas.com - Big Investing Ideas

We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders.  Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast ,  Cleantech and Climate Change Podcast,  Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast.  We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water. 

 

The Investorideas.com podcasts are also available on Apple Podcasts ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts  and most audio platforms available.

 

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Disclosure: podcast sponsor AppTech Payments Corp. (NasdaqCM:APCX) is a paid featured Fintech company on Investorideas.com. Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Cryptocurrency Disclaimer

Investorideas.com news content is not meant to be a solicitation to buy or sell cryptocurrencies and Investorideas.com does not directly sell cryptocurrencies; but acts as a news and research resource for interested investors following the blockchain sector.

Copyright and ownership: Crypto Corner is an Investorideas.com content brand

 

 Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800-665-0411 

 



Get more Bitcoin and Blockchain Investor ideas  – news, articles, podcasts and stock directories